Healthcare -
Biotechnology - NASDAQ - US
$ 4.39
-1.84 %
$ 37.9 M
Market Cap
-0.36
P/E
KPTI - TOTAL CURRENT LIABILITIES
Total Current Liabilities KPTI - Karyopharm Therapeutics Inc.
92.3 M
LAST VALUE
18.32%
2 YEAR CAGR
14.76%
5 YEAR CAGR
22.32%
10 YEAR CAGR